Alexandria Real Estate Equities (NYSE:ARE) is a real estate investment trust, or REIT, that focuses on properties for the life science industry. The company states it has a strong balance sheet and a high credit rating among U.S. REITs, reflecting its robust financial health. It is currently funding its 2026 capital needs by selling certain assets, a strategic move in its real estate investment portfolio.
On April 27, 2026, Alexandria Real Estate Equities reported its first-quarter financial results. The company announced a net income of $2.10 per share, as highlighted by PR Newswire. This Q1 earnings result significantly surpassed the consensus analyst estimate of $0.14 per share, indicating much stronger profitability than expected for the quarter, a key insight for investors.
However, the company's revenue of $671.02 million for the quarter fell short of the estimated $684.78 million. This revenue figure also marks an 11.5% decline from the same period in the previous year. Despite this revenue miss, the reported revenue did slightly exceed the Zacks Consensus Estimate of $668.65 million, offering a mixed picture of its quarterly revenue performance.
A key performance measure for REITs is Funds From Operations (FFO), which shows the cash generated by operations. Alexandria Real Estate Equities reported an adjusted FFO of $1.73 per share, which met the Zacks Consensus Estimate. This FFO is lower than the $2.30 per share reported in the same quarter a year ago, providing context for its FFO analysis. The company's Price-to-Sales ratio, which compares its stock price to its revenues, stands at 2.72, offering another perspective on its market valuation.
